Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Kaisa Health Group Holdings Limited ( (HK:0876) ) has issued an update.
Kaisa Health Group Holdings Limited reported a sharp revenue decline to HK$139.1 million for 2025 from HK$185.4 million a year earlier, as rising selling and distribution expenses and increased research and development costs pressured margins. Despite booking a gain from changes in fair value of financial assets and reduced administrative expenses, the group posted a net loss of HK$46.8 million, only slightly narrower than the prior year’s HK$50.6 million loss.
The company’s basic and diluted loss per share widened marginally to 0.93 Hong Kong cents, reflecting ongoing operational challenges and impairment charges on receivables. Nevertheless, foreign exchange translation gains significantly improved other comprehensive income, reducing total comprehensive loss to HK$28.0 million from HK$65.0 million, offering some relief to stakeholders concerned about the group’s overall financial position.
The most recent analyst rating on (HK:0876) stock is a Hold with a HK$0.17 price target. To see the full list of analyst forecasts on Kaisa Health Group Holdings Limited stock, see the HK:0876 Stock Forecast page.
More about Kaisa Health Group Holdings Limited
Kaisa Health Group Holdings Limited is a Bermuda-incorporated company listed in Hong Kong that operates in the healthcare sector. The group focuses on health-related products and services, generating revenue primarily from its consolidated operations in Greater China and related markets.
YTD Price Performance: 78.57%
Average Trading Volume: 19,553,190
Technical Sentiment Signal: Buy
Current Market Cap: HK$630.3M
Learn more about 0876 stock on TipRanks’ Stock Analysis page.